ATE370155T1 - Verfahren zur herstellung von funktionalisierten beta-(1,3)-glucanderivaten - Google Patents

Verfahren zur herstellung von funktionalisierten beta-(1,3)-glucanderivaten

Info

Publication number: ATE370155T1
Authority: AT; Austria
Prior art keywords: derivatives; glucander; beta; formula; producing functionalized
Prior art date: 2000-02-04

Application number

AT01904046T

Other languages

English (en)

Inventor

Jean-Claude Yvin

Frank Jamois

Vincent Ferrieres

Daniel Plusquellec

Original Assignee

Goemar Lab Sa

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2000-02-04

Filing date

2001-02-02

Publication date

2007-09-15

2001-02-02 Application filed by Goemar Lab Sa filed Critical Goemar Lab Sa

2007-09-15 Application granted granted Critical

2007-09-15 Publication of ATE370155T1 publication Critical patent/ATE370155T1/de

Links

238000004519 manufacturing process Methods 0.000 title 1
238000000034 method Methods 0.000 abstract 2
229920002498 Beta-glucan Polymers 0.000 abstract 1
229910019142 PO4 Inorganic materials 0.000 abstract 1
QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 abstract 1
150000001875 compounds Chemical class 0.000 abstract 1
239000002537 cosmetic Substances 0.000 abstract 1
239000000937 glycosyl acceptor Substances 0.000 abstract 1
239000000348 glycosyl donor Substances 0.000 abstract 1
125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 abstract 1
229920001542 oligosaccharide Polymers 0.000 abstract 1
150000002482 oligosaccharides Chemical class 0.000 abstract 1
NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 abstract 1
239000010452 phosphate Substances 0.000 abstract 1
229910021653 sulphate ion Inorganic materials 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H5/00—Compounds containing saccharide radicals in which the hetero bonds to oxygen have been replaced by the same number of hetero bonds to halogen, nitrogen, sulfur, selenium, or tellurium
- C07H5/08—Compounds containing saccharide radicals in which the hetero bonds to oxygen have been replaced by the same number of hetero bonds to halogen, nitrogen, sulfur, selenium, or tellurium to sulfur, selenium or tellurium
- C07H5/10—Compounds containing saccharide radicals in which the hetero bonds to oxygen have been replaced by the same number of hetero bonds to halogen, nitrogen, sulfur, selenium, or tellurium to sulfur, selenium or tellurium to sulfur
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H13/00—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids
- C07H13/02—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
- C07H15/02—Acyclic radicals, not substituted by cyclic structures
- C07H15/04—Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Engineering & Computer Science (AREA)
General Health & Medical Sciences (AREA)
Biochemistry (AREA)
Biotechnology (AREA)
Genetics & Genomics (AREA)
Molecular Biology (AREA)
Crystallography & Structural Chemistry (AREA)
Chemical Kinetics & Catalysis (AREA)
Public Health (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Bioinformatics & Cheminformatics (AREA)
Veterinary Medicine (AREA)
Saccharide Compounds (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Polysaccharides And Polysaccharide Derivatives (AREA)
Steroid Compounds (AREA)
Cosmetics (AREA)

AT01904046T 2000-02-04 2001-02-02 Verfahren zur herstellung von funktionalisierten beta-(1,3)-glucanderivaten ATE370155T1 (de)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
FR0001429A FR2804684B1 (fr)	2000-02-04	2000-02-04	Procede pour la preparation de derives fonctionnalises de beta-(1,3)-glucanes

Publications (1)

Publication Number	Publication Date
ATE370155T1 true ATE370155T1 (de)	2007-09-15

Family

ID=8846670

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT01904046T ATE370155T1 (de)	2000-02-04	2001-02-02	Verfahren zur herstellung von funktionalisierten beta-(1,3)-glucanderivaten

Country Status (11)

Country	Link
US (1)	US6951934B2 (de)
EP (1)	EP1252171B1 (de)
JP (1)	JP2003523331A (de)
AT (1)	ATE370155T1 (de)
AU (1)	AU2001231973A1 (de)
CA (1)	CA2399161C (de)
DE (1)	DE60129929T2 (de)
ES (1)	ES2292557T3 (de)
FR (1)	FR2804684B1 (de)
PT (1)	PT1252171E (de)
WO (1)	WO2001057053A1 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US20050065114A1 (en) *	2003-09-23	2005-03-24	Jean-Claude Yvin	Therapeutical treatment with oligo-beta- (1,3) -glucans, drugs used in said treatment
US7070778B2 (en)	2003-10-30	2006-07-04	Laboratoire Goemar Sa	Therapeutical combination against cancer
FR2910322B1 (fr) *	2006-12-22	2009-10-30	Mer Soc Par Actions Simplifiee	Utilisation d'oligo-b-(1,3)-glucanes modifies pour le traite traitement de maladies du systeme immunitaire, oligo-b-(1,3) glucane-(1,3)-mannose, oligo-b-(1,3)-glucane-(1,3)-mannitol et leurs derives, ...
US20100076239A1 (en) *	2007-09-07	2010-03-25	University Of South Florida	Asymmetric cyclopropanation of electron-deficient olefins with diazo reagents
US9499575B2 (en) *	2012-11-16	2016-11-22	The Arizona Board Of Regents On Behalf Of The University Of Arizona	Synthesis of carbohydrate-based surfactants

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GR860379B (en) *	1985-02-22	1986-06-11	Akzo Nv	Novel disaccharide and trisaccharide derivatives of the lipid a type
US5721368A (en) *	1996-07-22	1998-02-24	Merck & Co. Inc.	Process for synthesizing carbapenem side chain intermediates
FR2777281B1 (fr) *	1998-04-14	2000-06-30	Goemar Lab Sa	Procede de synthese du d-laminaribiose

2000
- 2000-02-04 FR FR0001429A patent/FR2804684B1/fr not_active Expired - Fee Related
2001
- 2001-02-02 ES ES01904046T patent/ES2292557T3/es not_active Expired - Lifetime
- 2001-02-02 DE DE60129929T patent/DE60129929T2/de not_active Expired - Lifetime
- 2001-02-02 AT AT01904046T patent/ATE370155T1/de not_active IP Right Cessation
- 2001-02-02 AU AU2001231973A patent/AU2001231973A1/en not_active Abandoned
- 2001-02-02 CA CA2399161A patent/CA2399161C/en not_active Expired - Fee Related
- 2001-02-02 US US10/182,976 patent/US6951934B2/en not_active Expired - Fee Related
- 2001-02-02 EP EP01904046A patent/EP1252171B1/de not_active Expired - Lifetime
- 2001-02-02 PT PT01904046T patent/PT1252171E/pt unknown
- 2001-02-02 JP JP2001557884A patent/JP2003523331A/ja active Pending
- 2001-02-02 WO PCT/FR2001/000329 patent/WO2001057053A1/fr not_active Ceased

Also Published As

Publication number	Publication date
DE60129929T2 (de)	2008-04-30
US20030045706A1 (en)	2003-03-06
JP2003523331A (ja)	2003-08-05
CA2399161C (en)	2010-10-12
CA2399161A1 (en)	2001-08-09
EP1252171B1 (de)	2007-08-15
FR2804684A1 (fr)	2001-08-10
AU2001231973A1 (en)	2001-08-14
DE60129929D1 (de)	2007-09-27
EP1252171A1 (de)	2002-10-30
PT1252171E (pt)	2007-11-15
US6951934B2 (en)	2005-10-04
FR2804684B1 (fr)	2002-06-28
WO2001057053A1 (fr)	2001-08-09
ES2292557T3 (es)	2008-03-16

Similar Documents

Publication	Publication Date	Title
UA42734C2 (uk)	2001-11-15	Водорозчинна сіль німеcуліду, водний розчин солі німеcуліду, композиції на основі німеcуліду, спосіб отримання водорозчинної солі німеcуліду та фармацевтична композиція для лікування запалювальних захворювань
DE60202958D1 (de)	2005-03-17	Stabiles polymorph von flibanserin, industrielles verfahren zu dessen herstellung und dessen verwendung zur herstellung von medikamenten
DE602006004719D1 (de)	2009-02-26	Verfahren zur herstellung von cellulosesulfat mit verbesserten eigenschaften
DK1158962T3 (da)	2003-01-06	Fremgangsmåde til fremstilling af faste cyclodextrinholdige doseringsformer
DE69941991D1 (de)	2010-03-18	Verfahren zur Herstellung von L-Aminosäure
MEP9309A (en)	2011-12-20	Novel oligosaccharides, preparation method and pharmaceutical compositions containing the same
BR0113580A (pt)	2003-07-15	Combinações de substâncias ativas com propriedades inseticidas e acaricidas
EP1493754A4 (de)	2007-03-14	Polysaccharid mit phosphorylcholingruppe und herstellungsverfahren dafür
DE69818091D1 (de)	2003-10-16	Verfahren zur herstellung von derivaten von brommethyl-biphenyl verbindungen
DE60208784D1 (de)	2006-04-06	Clathrat von azithromycin-hydrat mit 1,2-propylenglykol, verfahren zu dessen herstellung und dieses enthaltende pharmazeutische zusammensetzung
DE60129929D1 (de)	2007-09-27	Verfahren zur herstellung von funktionalisierten beta-(1,3)-glucanderivaten
DE69923426D1 (de)	2005-03-03	Verfahren zur herstellung von isoflavonen
DE602004011921D1 (de)	2008-04-03	Verfahren zur herstellung von (4-hydroxy-6-oxo-tetrahydropyran-2-yl) acetonitril und dessen derivaten
ATE356173T1 (de)	2007-03-15	Oberflächenbehandeltes bariumsulfat und verfahren zu dessen herstellung
ATE415404T1 (de)	2008-12-15	Lösungsmittelfreies verfahren zur herstellung von diketopyrrolopyrrol-derivaten
DE59712943D1 (de)	2008-07-10	Verfahren zur herstellung von (s)- oder (r)-3,3,3-trifluor-2-hydroxy-2-methylpropionsaüre
DE60041137D1 (de)	2009-01-29	Ceramid ähnliche verbindungen, verfahren zu deren herstellung und deren verwendung als antitumormittel
DE69926223D1 (de)	2005-08-25	Verfahren zur herstellung von zwischenprodukten
DE60013326D1 (de)	2004-09-30	Verbindungen und verfahren zur behandlung von schmerz
EP1132383A4 (de)	2002-04-17	Neuartige agarofuran derivate, ihre herstellung, pharmazeutische zusammensetzungen, die diese enthalten und ihre verwendung als medizin
DE50205794D1 (de)	2006-04-20	Verfahren zur herstellung fester formulierungen von natrium-3-hydroxy-3-methylbutyrat
ATE346510T1 (de)	2006-12-15	Gelierzucker und verfahren zu dessen herstellung
DE60013583T8 (de)	2006-06-08	Verfahren zur herstellung von arzneimitteln eines basischen hydrophoben wirkstoffs
YU81502A (sh)	2006-05-25	Ciklopostini, postupak za njihovu proizvodnju i njihova primena
DE60031315D1 (de)	2006-11-23	Verfahren zur Herstellung von Derivaten von i(1,5-Diaryl)pyrazol-3-ylöpropansäure

Legal Events

Date	Code	Title	Description
2008-02-15	RER	Ceased as to paragraph 5 lit. 3 law introducing patent treaties